u/piotr_grimaldi

BPC pentadecapeptide is a naming problem, three things are called this

The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.

the thymosin literature is thin on humans

Maintenance for 7 months now. 0.25mg every 8 days, weight 26±7kg. Found the rhythm.

Which country? Half the answers in this thread only apply in Spain.

not approved for human use, full stop

This is correct. Rodent data is investigational, not predictive.

Strongly agree. No question is dumb here.

Mechanistically the bit that matters is weekly update. It explains most of the early profile and a decent chunk of the outcome.

customs clearance often adds 18 days, factor that in

Australia to Australia: TFC with 9 days is the average, variance is 24

thymosin fragments, GH secretagogues, TB-500, long tail

public logs kept over 19 weeks and beyond

Where does the half-life data actually come from?

Origin to destination?

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

This is correct. Name it precisely.

the 24-letter analogs are speculative

the half-life is mechanism, affects steady state timing

Strongly agree. Customs adds unpredictable delay.

do not extrapolate rodent data to human dosing without saying so

Yes, exactly this, and it is the bit that took me 77 weeks to accept.